Olesen Anne Estrup, Staahl Camilla, Ali Zahid, Drewes Asbjørn Mohr, Arendt-Nielsen Lars
Center for Visceral Biomechanichs and Pain, Department of Medical Gastroenterology, University Hospital Aalborg, Aalborg, Denmark.
Basic Clin Pharmacol Toxicol. 2007 Sep;101(3):172-6. doi: 10.1111/j.1742-7843.2007.00095.x.
By combining drugs with different mechanisms of action, synergistic effects may be achieved. The aim of the present experimental pain study was to combine paracetamol with dextromethorphan for synergistic effects. Furthermore, the reproducibility of the pain assessment methods was evaluated. Eighteen volunteers completed all periods in a three-way cross-over study. Pain stimuli were assessed at baseline and 1, 2 and 3 hr after dosing. The aim was to compare the pain-alleviating effect of 1 g paracetamol, 1 g paracetamol plus 30 mg dextromethorphan and placebo in response to a number of different stimuli in a human experimental volunteer model of skin and muscle pain. Repeated electrical stimulation of skin and muscle (temporal summation) modelled central integration and intramuscular hypertonic saline mimicked musculoskeletal pain. The method provided statistically stable pain recordings between repetitions on the same day and between days (all P > 0.05). Between repetitions on the same day, all tests were reproducible within the participants (intra-class correlation > 0.60). Between days all tests, except muscular pain pressure threshold, were reproducible within the participants (intra-class correlation > 0.60). There were no statistical differences (all P > 0.05) between paracetamol compared to placebo, and between the effect of paracetamol and dextromethorphan compared to placebo. The acute pain models were not sufficiently sensitive to detect an analgesic effect of paracetamol or the combination with dextromethorphan. The selected dose of dextromethorphan was low as the aim was to use commonly used doses, and a higher dose of dextromethorphan is most likely needed to attenuate the selected pain measures.
通过联合使用具有不同作用机制的药物,可能会产生协同效应。本实验性疼痛研究的目的是将对乙酰氨基酚与右美沙芬联合使用以实现协同效应。此外,还评估了疼痛评估方法的可重复性。18名志愿者完成了一项三向交叉研究的所有阶段。在给药前基线以及给药后1、2和3小时评估疼痛刺激。目的是在皮肤和肌肉疼痛的人体实验志愿者模型中,比较1克对乙酰氨基酚、1克对乙酰氨基酚加30毫克右美沙芬和安慰剂对多种不同刺激的镇痛效果。对皮肤和肌肉的重复电刺激(时间总和)模拟中枢整合,肌肉内高渗盐水模拟肌肉骨骼疼痛。该方法在同一天的重复测量之间以及不同天之间提供了统计学上稳定的疼痛记录(所有P>0.05)。在同一天的重复测量之间,所有测试在参与者内部都是可重复的(组内相关>0.60)。在不同天之间,除肌肉疼痛压力阈值外,所有测试在参与者内部都是可重复的(组内相关>0.60)。与安慰剂相比,对乙酰氨基酚之间以及对乙酰氨基酚与右美沙芬联合使用与安慰剂相比,均无统计学差异(所有P>0.05)。急性疼痛模型对检测对乙酰氨基酚或其与右美沙芬联合使用的镇痛效果不够敏感。所选右美沙芬剂量较低,因为目的是使用常用剂量,很可能需要更高剂量的右美沙芬来减轻所选的疼痛指标。